Data & Analytics
| Title | Summary | Presenter/Author | Subject Area | Type | hf:doc_tags | hf:doc_author |
|---|---|---|---|---|---|---|
| December 2024 Journal Club – PrEP and HIV Risk Among People Who Inject Drugs: Lessons from the Penobscot Cluster |
Maine has been spared from a high burden of HIV, making transmission among people who … |
Andrea Truncali MD MPH | Data & Analytics, Educational Resources | Journal Club, Newsletter | journal-club newsletter | andrea-truncali-md-mph |
| October 2024 Journal Club – Initiating MOUD Without Withdrawal: ED Trial of Injectable Buprenorphine (Brixadi) in Patients With Minimal Withdrawal |
Precipitated withdrawal (PW) is a deterrent to initiating MOUD for both patients and providers. Experiencing … |
Andrea Truncali MD MPH | Buprenorphine, Data & Analytics, Withdrawal Management | Journal Club, Newsletter | journal-club newsletter | andrea-truncali-md-mph |
| April 2024 Journal Club – ADHD Pharmacotherapy Showed a Signal for 2year Mortality Reduction But is Likely Healthy User Bias |
This headline grabbing paper recently came through, and also pops up on the wellknown point … |
Andrea Truncali MD MPH | ADHD, Data & Analytics | Journal Club, Newsletter | journal-club newsletter | andrea-truncali-md-mph |
| December 2023 Journal Club- Effectiveness of Prazosin in AUD Study |
Alcohol use disorder (AUD) is a disease that affects one in seven people. 1 And … |
Andrea Truncali MD MPH | Alcohol Use Disorder, Data & Analytics | Journal Club, Newsletter | journal-club newsletter | andrea-truncali-md-mph |
| October 2023 Journal Club – Fentanyl Toxicology Testing 16 vs 24 mg: Beyond the Headlines |
Greetings, colleagues! In the era of fentanyl, we wonder, is more buprenorphine better? Or does … |
Andrea Truncali MD MPH | Data & Analytics, Fentanyl | Journal Club, Newsletter | journal-club newsletter | andrea-truncali-md-mph |
| May 2023 Journal Club- Precipitated Withdrawal in the Fentanyl Era: Reassessing Risk Perception Through New Data |
Some of you remember the days when precipitated withdrawal (PW) felt mostly theoretical. It was … |
Andrea Truncali MD MPH | Data & Analytics, Withdrawal Management | Journal Club, Newsletter | journal-club newsletter | andrea-truncali-md-mph |
| January 2023 Journal Club – Atomoxetine and OROS methylphenidate performed similarly in patients with comorbid major depression and ADHD |
Imagine yourself sitting around table drinking morning coffee with your colleagues and talking shop. Reading … |
Andrea Truncali MD MPH | ADHD, Data & Analytics, Stimulant Use | Journal Club, Newsletter | journal-club newsletter | andrea-truncali-md-mph |
| Agency for Healthcare Research and Quality Opioids and Substance Use Disorder |
Agency for Healthcare Research and Quality: A Profile The Agency for Healthcare Research and Quality … |
Data & Analytics | ||||
| Data Collection: Assessing the Complex Patient |
April 5, 2022 | Todd Mandell, MD, FASAP The presenter will explore how to assess and use evidence based resources and tools to begin to identify the interrelations between SUD and psychiatric conditions to direct treatment approaches. Interactive case studies will be used for discussion. Learning objectives: Identify ways that SUD can mimic functional psychiatric conditions. |
Todd Mandell | Co-Occurring, Data & Analytics, Screening | todd-mandell |